What was Instadose Pharma’s price range in the past 12 months?
Instadose Pharma lowest stock price was $0.24 and its highest was $0.25 in the past 12 months.
What is Instadose Pharma’s market cap?
Instadose Pharma’s market cap is $53.19K.
When is Instadose Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Instadose Pharma overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Instadose Pharma pay dividends?
Instadose Pharma does not currently pay dividends.
What is Instadose Pharma’s EPS estimate?
Instadose Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Instadose Pharma have?
Instadose Pharma has 531,933,800 shares outstanding.
Which hedge fund is a major shareholder of Instadose Pharma?
Currently, no hedge funds are holding shares in INSD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Instadose Pharma
Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Antonio Rocco Franchino
Employees
2
Website
www.instadosepharma.com
Address
5500 North Service Road, Burlington, ON, L7L 6W6, CA